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CURRENT VIEWS ON THE TREATIMENT OF 
PORT'AL HYPERTENSION 
A. CUSCHIERI 
Department of Swrgery, University Of Dundee 
There is no established treatment pro-
tocol for bleeding oesophageal varices on 
which there is universal agreement be-
twe€Jn s'urgeons and physicians with spe-
cial interest in the subject of portal hy-
pertension. In general, the outlook for 
these patients is poor irrespective of 
troatment and the single most important 
factor in determining the prognos;s in the 
individual case, is the nature and progress 
of the underlying liver disease with the 
attendant overall hepatocyte fUnction. 
This article attempts to review current 
views on the subject of therapy for por-
tal hypertension and proposes a rational 
programme of management for these pa-
tients whch is influenced by the author's 
personal experience. 
Classificaton of Porta! Hypertens10n. 
The various disorders associated with 
portal hypertensicn have been recently re-
classified by Ma!t (1976) into pre-paren-
chymar, pnrenchymal and post-parenchy-
mal blocks. The pre-parenchymal group 
comprises most of the entities often re-
ferred to as oxtra-hepatic blocks such 2S 
congenital or adult thrombosis of the por-
tal vein. The parenchymal group includes 
a number of disorders which produce ob-
struction without hepatocel;u~ar dysfunc-
tion (Schistosomiasis, congenital hepatic 
fibrosis and cysts) and cirrhosis where, 
in addition to a parenchymal block to the 
liver blood flow, a varying but usually 
progressive state of hepatocellular de-
compensation is present. Cases of chro-
nic hepatic vein obstruction (thrombosis, 
veno-occl usive disease, congenital diaph-
ragm in the vena cava or heart disease) 
constitu:e the post-parenchymal group. 
Em0~gency Treatment of B!eed:ng 
OeSOph8;)eal Varices 
The essential steps necessary for these 
patients are - diagnosis of the bleeding 
site', cossation of the haemorrhage and the 
ins'dtution of supportive measures fol-
lowed by a period of assesment of the 
patient once the situation is under con-
trol. 
It is important to stress that not all pa-
tients with portal hypertension bleed from 
their varices. In some of the patients, the 
sources of the bleeding is a chronic duo-
rlenal ulcer and indeed the incidence ot 
peptic ulceration in cirrhotic patients is 
higher than that of the general population. 
Barium m8al studies and, in particular, 
fibreoptic endoscopy are therefore re· 
quired in order to establish with certain-
ty the bleeding site. The methods avail-
able for the control of the b:eeding include 
the administraticn of Pitressin, bal:oon 
tamponade and the direct injection of the 
bleeding varices with Sclerosant solu-
tions. 
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GRAFT 
The value of Pitrossin is now estab- VENA 
CAVA lished.ln the author's experience, Pitres-
sin administered intravenously in a dose 
of 20 units in 200 m! of saline over a 
period of twenty minutes, resulted in the 
cossation of the bleeding in 75 per cent 
of cases. More recently, Pitressin has 
been administered as an intraarterial in-
fusion via a catheter introduced into the 
superior mesenteric artery using the Sel-
dinger technique (Nusbaum et all., 1968). 
The advantage of this method lies in the 
much lower dose of Pitressin required 
and therefore a potential reduction of 
possible side effects especially on the 
myocardium. On the other hand, it is a 
rather complicated technique which ne-
cessitates an in-dwelling Seldinger cathe-
ter and pump perfusion and it is there-
fore not without certain arterial and 
infective risks, which may contribute 
to the demise of the patient (Berardi, 
1974). Indeed a recent study showed 
distinct disadvantagos with this technique 
of administering Pitressin (Murray-Lyon, 
et aI., 1973) and the author has 
abandoned its use.·t is important that 
the biological activity of Pitressin is asses-
sed by the occurrence of a massive bowel 
action which shou'd 'follow within a few 
minutes of its administration and which is 
of therapeutic benefit as the resultant me-
laena reduces the protein load in the intes-
tinal lumen. Intravenous Pitressin acts by 
:owering the portal venous pressure and, 
in the author's opinion, it is still an ex-
t;emely useful first-line measure in the im-
mediate management of bleeding oesopha-
geal varices. 
Balloon t3mponade is certainly effective 
in controlling bleeding but carries certain 
hazards (Bauer, 1974; Pitcher, 1971). The 
Fig. 1: Synl.hetic graft (Gore-Tex) between 
the pcrtal vein Gind the inferior vena cava. 
most commonly used tube is the Sengs-
taken-B!akemore tube which is best insert-
ed lubricated, via the nasal route down to 
50 centimetres. The gastric balloon is in-
flated with 200 mls of a:r and slight trac-
tion is applied after which the tube is 
strapped to the forehead. Only if bleedir:lg 
is not controlled in this way is the oesopha-
gea!1 balloon .inflated to about 4 millimetres 
of mercury. In this situation, a sma:1 naso-
gastric tube is also inserted into the oespha-
gus proximal to the inflated oesophageal 
balloon to prevent aspirartion. The compli-
cations of balloon tamponade inclUde 
erosion and further blee'ding, airway oc-
clusion and aspiration pneumonitis. 
With strict vigilance, the complication rate 
and morality from its use can be kept at 
acceptab:e low levels (10-12 per cent). In 
any event, defla,tion of the balloon should 
be carried out at 24 hours and, if the 
bleeding recurs, then emergency surgery 
should be seriously contemplated. 
There has been a revival in recent years 
of the procedure of sclerosant injection of 
the oesphageal varices. The author has no 
practical experience of the technique but 
the best results have been reported when 
the technique is :used after the bleeding 
has been controlled by gastric bol:oon 
tamponade. 
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TABLE 1 
CLASSIFICATION OF PATIENTS WITH CIRRHOSIS (Child, 1964) 
Group A B C 
Serum bilirubin 
(mg/100 ml) 
Serum albu'T!';n 
(g/100 ml) 
Ascites 
Neuro:togical disordAr 
Nutrition 
<2.0 
>3.5 
None 
None 
Excellent 
Correction of hypovo:aemia is best 
achieved by the administration of fiGsh 
blood and should be carried out with cen-
tral venous pressure monitoring. In addi-
tion, these patients usually have coagula-
tion defects clue to multifactorial defic:en-
cies which require correction by the ad-
ministration of dotting factor concentrates 
in addition to parenteral Vitamin 1<. 
Measures designed to prevent porto-
systemic encephalopathy such as the ad-
ministration of neomycin or iactulose to-
gether with magnesium sulphate enemata, 
correction of fluid and electrolyte abnorma-
lities (in particular hypokalaemia) and the 
administration of intravenous Dextrose (10 
per cent) should be commenced forthwith. 
The level of coma is best assessed by 
E.E.G. monitoring. 
The cessation of the bleeding episode 
either by vasopressin or by balloon tamp-
onade allows of time fOr evaluation of the 
patient, with regard to his general condi-
tion, the state of hiS liVEr function and his-
tology, the patency of his portal venous 
system and his b:ood clotting status. A 
decision is thereby reached: using Child's 
criteria shown in Table 1 as to whether 
the patient comes into Child's category A, 
B or C. All Childi A and some B cases are 
suitab!e for shunting shou:d bleeding recur, 
whereas Child C patients are not, as their 
advanced liver disease imposes a prohibi-
tive immediate post-operative mortality in 
excess of 50 per ce:1t (Malt, 1976). All 
Child C patients should therefore have non-
shur.ting procecQ1rei> if surgery is contem-
2.0-3.0 >3.0 
3.0-3.5 <3.0 
Easily Poorly 
controi!ed controlled 
Minimal Advc.nced 
"coma " 
Good POOr 
"wasting" 
plated because of contin ued haemorrhage. 
Liver histology when available, may have 
an important bearing on the type of smgi-
calcal intervention as patients with acute 
hya:ine change have a poor prognosis after 
shunting as do patients with chronic active 
hepatitis. 
Shunt Surgery versus Long Term 
Conservative Medcal Treatment 
In the past, a strong argument has been 
made for the use of prophylactic shunt 
operation i.e. operations performed in pa-
tients with porta'l hypertens,ion and oeso-
phageal varices before any bleediing epi-
sodes, in order to prevent the occurrence 
of variceal haemorrhage. However, there 
has now been a number of prospective ran-
domised controlled clinical trials (Jackson 
et ai, 1968; Resniok et ai, 1969; Conn and 
Lindilenmuth, 1965; Conn et ai, 1972) 
which have shown that prophylactic shunt 
operations do not impart any real benefit 
to these patients but alter the cause of 
death from variceal haemorrhage to liver 
failure. Moreover, prophylactic shunt oper-
ations in fact result in a decreased survival 
time. These clinical trials have conclusive-
ly proved that there is no indication for 
prophylactic shunt surgery. 
The question of a therapeutic shunt is 
stll highly controversial. Recent controlled 
clinical stJ dies comparing therapeutic 
shunts i.e. a shunt operation carried' out 
after bleeding has occurred versus conser-
vative trea1Jment (Jackson et ai, 1971; Res-
nick et ai, 1974) have indiciated' no signifi-
cant differences in survival between these 
two approaches. However, in these tria's 
patients with liver disease of varying seve-
rities were lumped together and indeed in 
some of the studies, some of the patients 
that were originally al!ocated to the conser-
vative treatmont group were subsequently 
shunted. Since it is known that only pa-
tients with Child group A and some cases 
of Child group B do well after shunt sur-
gery, a more val,:d comparison is between 
shunt surgery and continued cons('rvative 
medical treatment in patients with good 
liver fLnction. The preliminary report of 
Mikkelsen (1974) of patien's who had b!ed 
ot least once from varices and who wero 
under 60 years of age and classified as 
Child Group A, has shown that med:cal 
treatment (38 patients) resu:ts in a 10 
per cent five-year survival as opposed to 
60 per cent five-year survival following 
shunt operation (37 patients). 
Non-Shuntfng Procedures 
There are a number of these operations. 
They include Boerema-Crile transoGsopha-
g€Jal ligation, oesophageal transection, por-
to-azygous disconnection of Tanner, splen-
ectomy and devascularisation, the Boere-
ma-Cri!e button, oesophagogastrectomy 
etc. The one main advantage of all these 
procedures is the retention of a high pres-
sure venous zone adjacent to a low pres-
sure one and this u!tirrrately leads to th8 
recurrence of the varices and therefore to 
recurrent haemorrhage. Nevertheless, they 
are the operations of choice in patients 
with nOl1mal hepatocytes and a high portal 
blood flow s!..lch as patients with Schisto-
somiasis 'cavernous trans·fonmation of 
the portal vein if and when conservative 
treatment fails. The operation most favour-
ed! in this group of patients in view of the 
good results obta,ined is splenectomy and 
deva,scularisation. For patients with ad-
vanced liver disease (Child C) who con-
tinue to bleed, the author favours the oeso-
phageal transection procedure of Wa,:ker . 
The immediate mortality in this group is 
high, and the prognosis fOr those that sur-
vive the operation is ex,tremely poor. It is 
therefore debatable whether surgica'l inter-
vention is indicated even in the presence of 
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Fig. 2: W~':T3nt ShU;l:t. (Top) shows the 
completed proce~ure with the re~evant 
cmrJ1:omy. (Bottom) Detc:.j~s the anastomo-
sis betwe.en the splen;c vein and the renal 
vein. 
continued or recurr::'nt bleeding. In the final 
analysis, the decision 0; whether or not to 
operate is based chiefly on moral grounds. 
Shunt Operations 
The various types of shunt operations 
are shown ill Tab!e 2. The most established 
operation and the one that is often used 
as the yardstick against which all other 
shunt procedures are compared,is the 
portacaval shunt. The end-to-side portaca-
val shunt has been favoured by most sur-
geons in preference to the side-to-side 
variety largely because of technical consi-
derations. On haemodynamic gro,unds of 
course the side-to-side portacaval shunt 
is a better procedure and is the operation 
TABLE 2 
SOME OF THE MORE POPULAR 
SHUNT OPERATIONS 
I. Portasystemic shunts -
A. Portacaval: end-to-side 
side-to-side 
interposition (H) graft 
B. Splenorenal. 
C. Mesocaval: end-to-side 
interposition (H) graft 
0, "Makeshift". 
11. Shunts causing selective decompres-
sion. 
A. Warren's trans-splenic decompression. 
B. I.ceft gastric - vena caval shunt. 
of choice in the presence of ascites and 
reversed portal blood flow. However, it is 
technically very difficult and has a higher 
thrombosis rate than the end-to-side por-
tacaval shunt. The more recent inter-posi-
tion graft procedure between either the 
portal vein and the vena cava (author's 
preference) or between the superior me-
senteric ve!n and the vena cava is, in fact, 
a type of side-to-side anastomosis which 
can be performed with relative ease and 
avoids the risk of tenting of the vessels 
and therefore of late thrombosis of t'he 
shunt. The author now tends to favour a 
portacaval shunt usin~ an interposed syn-
thetic (Gore-Tex) graft anastomosed end-
to-side to the inferior vena cava and the 
portal vein as shown in Figure 1. 
The concept of selective decompression 
of the portal venous system whereby the 
pressure at the site of the offending oeso-
phageal varices is reduced but the portal 
blood flow is not affected to any great ex-
tent is an attractive one. However, it is 
not based on any scientifically proven pre-
mise that retention of the portal venous 
blood in such patients is the important fac-
tor in determining whether or not deterior-
ation of liver function and encephalopathy 
occur after shunt surgery. Not infrequent-
ly, in patients with portal hypertE"nsion, 
effective portal flow through the liver is 
greatly reduced and in some the flow in 
the portal vein is reversed. The operation 
that has been most extensively investigat-
ed as a selective decompression procedure 
is that described by Warren et al (1974) 
and shown in Figure 2. Another type of 
selective shunt is that described by Jap-
anese workers (lnokuchi et ai, 1975) which 
consists of an anastomosis between the 
left gastric coronary vein and the inferior 
vena cava using an interposed saphenous 
vein graft. The author has obtained good 
results with the Warren procedure but the 
operation is technically very difficult and 
had to be abandoned in 3 out of 12 pa-
tients. It is also highly debatab:e whether 
one needs to devascularise the stomach af-
ter the completion of the dista,1 splenorenal 
shunt as recommended by Warren et a!. 
In patients with portal hypertension in 
whom hepatocyte function is normal, e.g. 
Schistosomiasis and cavernous transfor-
fation of the portal vein, non-shunting oper-
ations should be performed in the first in-
stnnca. Severe encephalopathy will a:most 
cert.:,inly develop after any form of porta-
caval shunt but is less likely after a spleno-
ronal shunt; so that this becomes the shunt 
operation of choice in these pat.ients should 
bleeding recur after a non-shunting proce-
dure. 
The complications of shunt operations 
include recurrence of haemorrhage and en-
cepha:opathy. Recurrence of haemorrhage 
after shunt operation is the result of th rom-
bosis of the shunt; and, in general, the re-
current haemorrhage rate after a portacaval 
sh unt is of the order of three to five per 
cent. Encephalopathy is a problem. A re-
cent randomised but not blind study has 
shown that the incidence of encephalo-
pathy in patients with alcoholic cirrhosis 
is doubled in little over four years even 
without a shunt, whereas after portacaval 
shunt, the incidence dur:ing the same period 
increased from 20 to 53 per cent. The dif-
ference between these two groups was 
not significant (Mutchnick et ai, 1974). 
However, the incidence of acute encepha-
lopathy after shunting is more than twice 
as common as in the non-shunted group 
and the difference was significant. In gene-
ral, the incidence and severity of encepha-
lopathy is less after a splenorenal than a 
portacaval shunt. The incidence of ence-
phalopathy is also low after the selective 
decompression procedures. 
Conclusion 
It is now generally accepted that patients 
with pre-parenchymal blocks and paren-
chyma) b!ocks with normal hepatocyte 
function are best treated in the first in-
stance by non-surgical measures. Cirrhotic 
patients with varices who have not ble:1 
should not be treated surgically. In the 
presence of h!eeding varices in 'these pa· 
tients, the choice of treatment is dic~ated 
by the overall general condition and i.he 
liver fun cion together with the details of 
the histology of the liver. In good r:sk pa-
tients (Child A and some Chi:d B) the 
evidence available suggests that a thera-
peutic shunt is probably the best form of 
treatment in that it is accompanied by a 
low immediate mortal.ity and a five-year 
survival rate of about 60 per cent. On the 
other hand, the patients with more ad-
vanced liver disease and with poor gene-
ral condition should not, in the first in-
stance, be treated surgically. In the pre-
sence of recurrence or continuance of the 
haemorrhage in th;s group of patients, then 
a difficult decision has to be made. On 
moral grounds alone, very often one has 
to resort to emergency surgery which 
shou:d take the form of a non-shunting 
procedure. The ultimate prognosis of these 
patients is of course extremely poor. 
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